J Neurooncol. 2000 May;47(3):239-51.

Genetic basis of intramedullary spinal cord tumors and therapeutic implications.

Parsa AT, Fiore AJ, McCormick PC, Bruce JN.

Source

Department of Neurological Surgery, Columbia Presbyterian Medical Center, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA. ap239@columbia.edu

Abstract

The advent of molecular biology has provided tools to delineate genetic mutations that cause disease. Recently, several genetic mutations have been associated with intramedullary spinal cord tumors. Concurrently, advances in micro-neurosurgical techniques have significantly decreased the morbidity of surgical resection. In this review, we describe the current understanding of genetic mutations in sporadic and familial intramedullary spinal cord tumors. The future success of innovative gene therapy protocols may depend upon establishing a cause and effect relationship between these genetic mutations and disease progression. Successful gene therapy will also depend upon increasing the efficiency of gene therapy vector delivery.

PMID:: 11016741; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Genes and Gene Therapy - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. [Neurosurgery. 1996]
Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas.
Birch BD, Johnson JP, Parsa A, Desai RD, Yoon JT, Lycette CA, Li YM, Bruce JN. Neurosurgery. 1996 Jul; 39(1):135-40.
Molecular genetic alterations on chromosomes 11 and 22 in ependymomas. [Int J Cancer. 2001]
Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
Lamszus K, Lachenmayer L, Heinemann U, Kluwe L, Finckh U, Höppner W, Stavrou D, Fillbrandt R, Westphal M. Int J Cancer. 2001 Mar 15; 91(6):803-8.
Review Genetics and molecular biology of intramedullary spinal cord tumors. [Neurosurg Clin N Am. 2006]
Review Genetics and molecular biology of intramedullary spinal cord tumors.
Chi JH, Cachola K, Parsa AT. Neurosurg Clin N Am. 2006 Jan; 17(1):1-5.
Review Application of advances in molecular biology to the treatment of brain tumors. [Curr Oncol Rep. 2000]
Review Application of advances in molecular biology to the treatment of brain tumors.
Takeshima H, Sawamura Y, Gilbert MR, Van Meir EG. Curr Oncol Rep. 2000 Sep; 2(5):425-33.
Review Genetics of nervous system tumors. [Hematol Oncol Clin North Am. 2...]
Review Genetics of nervous system tumors.
Shapiro JR. Hematol Oncol Clin North Am. 2001 Dec; 15(6):961-77.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Genetic basis of intramedullary spinal cord tumors and therapeutic implications.
Genetic basis of intramedullary spinal cord tumors and therapeutic implications.
J Neurooncol. 2000 May ;47(3):239-51.

PubMed
Relationship between apoE genotype and CSF beta-amyloid (1-42) and tau in patien...
Relationship between apoE genotype and CSF beta-amyloid (1-42) and tau in patients with probable and definite Alzheimer's disease.
Neurobiol Aging. 2000 Sep-Oct ;21(5):735-40.

PubMed
Radical surgery for gallbladder cancer: current options.
Radical surgery for gallbladder cancer: current options.
Eur J Surg Oncol. 2000 Aug ;26(5):438-43.

PubMed
Nitroglycerin is preferable to diltiazem for prevention of coronary bypass condu...
Nitroglycerin is preferable to diltiazem for prevention of coronary bypass conduit spasm.
Ann Thorac Surg. 2000 Sep ;70(3):883-8; discussion 888-9.

PubMed
[Treatment of tinnitus with low-intensity laser].
[Treatment of tinnitus with low-intensity laser].
Ugeskr Laeger. 2000 Jun 19 ;162(25):3607-10.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: